GENERIC PEPTIDE • PTH (1-34) TERIPARATIDE PTH (1-34) Teriparatide PTH (1-34) Teriparatide Sequence: H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH Molecular weight: 4117.8 PTH (1-34) Teriparatide Applications: Human Parathyroid Hormone (1-34) is used for treatment of osteoporosis in postmenopausal women who are at high risk for having a fracture. The drug is also approved to increase bone mass in men with primary or hypogonadal osteoporosis who have a high risk of bone fracture. PTH (1-34) Teriparatide Produced in: Torrance, US Documents available: DMF PTH (1-34) Teriparatide Specifications: PTH Teriparatide web spec 2021 PTH (1-34) Teriparatide Safety Data Sheet: PTH (1-34) Safety Data Sheet - EU See all products ASK FOR A QUOTE CONTACT US POLYPEPTIDE GROUP INFO INVESTORS CORPORATE NEWS OUR STORIES ABOUT US MEDIA CONTACT CONTACT US QUOTATION REQUEST CAREERS SOCIALS LINKEDIN FACEBOOK TWITTER YOUTUBE © Confidentiality 2021 PolyPeptide Group • Cookie management • Personal data • Sitemap ACTH (1-39) PorcineAtosibanCalcitoninCarbetocinDeslorelinDesmopressinExenatideFelypressinLeuprolideLiraglutideOctreotidePTH (1-34) TeriparatideSemaglutideSomatostatinTriptorelinVasopressin, 8-L-Arginine By clicking “Accept”, you consent to the use of ALL the cookies on our website . However you may visit Cookie Settings to provide a controlled consent. Cookie settingsACCEPT

PRE-GMP DEVELOPMENT Pre-GMP development We believe that investing the time in developing a robust production approach is essential to ensure the success of a product. With over 1000 GMP peptides manufactured within the Group, PolyPeptide offers the knowhow to develop the most efficient protocols in designing a cost-effective production approach. Furthermore, at PolyPeptide care is taken to develop the analytical characterization of any lead peptide designated for GMP manufacture as soon as the pre-development campaign starts. The key is to develop the necessary methods to uncover any impurities that may not be initially visible, in order to avoid potential problems at a later stage. The designed manufacturing scheme is then applied to the production of the initial pilot lots and pre-GMP animal toxicology lots. GMP Compliance GMP Inspections Pre-GMP development Production Quality Assurance Quality control Regulatory Support QUALITY CONTROL CUSTOM RESEARCH GRADE PEPTIDES PRODUCTION POLYPEPTIDE GROUP INFO INVESTORS CORPORATE NEWS OUR STORIES ABOUT US MEDIA CONTACT CONTACT US QUOTATION REQUEST CAREERS SOCIALS LINKEDIN FACEBOOK TWITTER YOUTUBE © Confidentiality 2021 PolyPeptide Group • Cookie management • Personal data • Sitemap ACTH (1-39) PorcineAtosibanCalcitoninCarbetocinDeslorelinDesmopressinExenatideFelypressinLeuprolideLiraglutideOctreotidePTH (1-34) TeriparatideSemaglutideSomatostatinTriptorelinVasopressin, 8-L-Arginine By clicking “Accept”, you consent to the use of ALL the cookies on our website . However you may visit Cookie Settings to provide a controlled consent. Cookie settingsACCEPT